| Literature DB >> 33499277 |
Elżbieta Paszek1, Wojciech Zajdel1, Tomasz Rajs1, Krzysztof Żmudka1,2, Jacek Legutko1,2, Paweł Kleczyński1,2.
Abstract
Atherosclerosis remains a large health and economic burden. Even though it has been studied for more than a century, its complex pathophysiology has not been elucidated. The relatively well-established contributors include: chronic inflammation in response to oxidized cholesterol, reactive oxygen species-induced damage and apoptosis. Recently, profilin 1, a regulator of actin dynamics emerged as a potential new player in the field. Profilin is abundant in stable atherosclerotic plaques and in thrombi extracted from infarct-related arteries in patients with acute myocardial infarction. The exact role of profilin in atherosclerosis and its complications, as well as its mechanisms of action, remain unknown. Here, we summarize several pathways in which profilin may act through mitochondria in a number of processes implicated in atherosclerosis.Entities:
Keywords: coronary artery disease; mitochondria; profilin 1
Mesh:
Substances:
Year: 2021 PMID: 33499277 PMCID: PMC7865810 DOI: 10.3390/ijms22031100
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923